PMID- 38178848
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240106
IS  - 1319-0164 (Print)
IS  - 2213-7475 (Electronic)
IS  - 1319-0164 (Linking)
VI  - 32
IP  - 1
DP  - 2024 Jan
TI  - The influence of telemedicine in primary healthcare on diabetes mellitus control 
      and treatment adherence in Riyadh region.
PG  - 101920
LID - 10.1016/j.jsps.2023.101920 [doi]
LID - 101920
AB  - Several studies have found that telemedicine has the potential to enhance the 
      outcomes of patients with diabetes. This study aimed to determine the impact of 
      telemedicine on the clinical outcomes of patients with type 2 diabetes mellitus 
      (T2DM) in Saudi Arabia. We conducted a cross-sectional study among T2DM patients 
      in selected primary healthcare centers in Riyadh, Saudi Arabia, from March 1, 
      2023, to August 20, 2023. We looked at how telemedicine affected HbA1c control, 
      adherence, the number of diabetic complications, and polypharmacy using adjusted 
      multivariable logistic regression models. Among the 583 patients, 140 (24.05 %) 
      received care via telemedicine, while 442 (75.95 %) received in-person care. 
      Patients who utilized telemedicine had significantly better glycemic control than 
      those who received in-person care only (AOR = 5.123, 95 % CI = 3.107-8.447). 
      Telemedicine also showed positive effects on treatment adherence (AOR = 2.552, 
      95 % CI = 1.6284-4.2414). Telemedicine can effectively reduce diabetic 
      complications (AOR = 0.277, 95 % CI = 0.134-0.571). Regarding polypharmacy, 
      patients with telemedicine use were less likely to report polypharmacy 
      (AOR = 0.559, 95 % CI = 0.361-0.866). Telemedicine is considered one of the 
      factors that improve HbA1c management and might increase therapeutic adherence 
      and reduce diabetic complications and polypharmacy.
CI  - (c) 2023 The Authors. Published by Elsevier B.V. on behalf of King Saud University.
FAU - Almalki, Ziyad S
AU  - Almalki ZS
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Imam, Mohammad T
AU  - Imam MT
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Ahmed, Nehad J
AU  - Ahmed NJ
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Ghanem, Rahaf K
AU  - Ghanem RK
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - S Alanazi, Taghreed
AU  - S Alanazi T
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - Juweria, Syeda
AU  - Juweria S
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - Alanazi, Taraf S
AU  - Alanazi TS
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - Alqadhibi, Raghad B
AU  - Alqadhibi RB
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - Alsaleh, Shadan
AU  - Alsaleh S
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - Hasino, Fadah H
AU  - Hasino FH
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - Saad Alsffar, Amirh
AU  - Saad Alsffar A
AD  - College of Pharmacy, Almmarefa University, Riyadh, Saudi Arabia.
FAU - I Alzarea, Abdulaziz
AU  - I Alzarea A
AD  - Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, 
      Aljouf, Saudi Arabia.
FAU - Albassam, Ahmed A
AU  - Albassam AA
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Alshehri, Ahmed M
AU  - Alshehri AM
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Alahmari, Abdullah K
AU  - Alahmari AK
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Alem, Ghada M
AU  - Alem GM
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Alalwan, Abdullah A
AU  - Alalwan AA
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
FAU - Alamer, Ahmad
AU  - Alamer A
AD  - Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz 
      University, Al-Kharj, Riyadh, Saudi Arabia.
LA  - eng
PT  - Journal Article
DEP - 20231213
PL  - Saudi Arabia
TA  - Saudi Pharm J
JT  - Saudi pharmaceutical journal : SPJ : the official publication of the Saudi 
      Pharmaceutical Society
JID - 9705695
PMC - PMC10765100
OTO - NOTNLM
OT  - Control
OT  - Diabetes mellitus
OT  - Healthcare
OT  - Telemedicine
OT  - Treatment adherence
COIS- The authors declare that they have no known competing financial interests or 
      personal relationships that could have appeared to influence the work reported in 
      this paper.
EDAT- 2024/01/05 06:43
MHDA- 2024/01/05 06:44
PMCR- 2023/12/13
CRDT- 2024/01/05 03:44
PHST- 2023/10/04 00:00 [received]
PHST- 2023/12/12 00:00 [accepted]
PHST- 2024/01/05 06:44 [medline]
PHST- 2024/01/05 06:43 [pubmed]
PHST- 2024/01/05 03:44 [entrez]
PHST- 2023/12/13 00:00 [pmc-release]
AID - S1319-0164(23)00415-2 [pii]
AID - 101920 [pii]
AID - 10.1016/j.jsps.2023.101920 [doi]
PST - ppublish
SO  - Saudi Pharm J. 2024 Jan;32(1):101920. doi: 10.1016/j.jsps.2023.101920. Epub 2023 
      Dec 13.